Expansion of memory Vδ2 T cells following SARS-CoV-2 vaccination revealed by temporal single-cell transcriptomics.
Journal
NPJ vaccines
ISSN: 2059-0105
Titre abrégé: NPJ Vaccines
Pays: England
ID NLM: 101699863
Informations de publication
Date de publication:
20 Mar 2024
20 Mar 2024
Historique:
received:
20
01
2023
accepted:
05
03
2024
medline:
21
3
2024
pubmed:
21
3
2024
entrez:
21
3
2024
Statut:
epublish
Résumé
γδ T cells provide rapid cellular immunity against pathogens. Here, we conducted matched single-cell RNA-sequencing and γδ-TCR-sequencing to delineate the molecular changes in γδ T cells during a longitudinal study following mRNA SARS-CoV-2 vaccination. While the first dose of vaccine primes Vδ2 T cells, it is the second administration that significantly boosts their immune response. Specifically, the second vaccination uncovers memory features of Vδ2 T cells, shaped by the induction of AP-1 family transcription factors and characterized by a convergent central memory signature, clonal expansion, and an enhanced effector potential. This temporally distinct effector response of Vδ2 T cells was also confirmed in vitro upon stimulation with SARS-CoV-2 spike-peptides. Indeed, the second challenge triggers a significantly higher production of IFNγ by Vδ2 T cells. Collectively, our findings suggest that mRNA SARS-CoV-2 vaccination might benefit from the establishment of long-lasting central memory Vδ2 T cells to confer protection against SARS-CoV-2 infection.
Identifiants
pubmed: 38509155
doi: 10.1038/s41541-024-00853-9
pii: 10.1038/s41541-024-00853-9
doi:
Types de publication
Journal Article
Langues
eng
Pagination
63Informations de copyright
© 2024. The Author(s).
Références
Chemaitelly, H. et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N. Engl. J. Med. 385, e83 (2021).
pubmed: 34614327
doi: 10.1056/NEJMoa2114114
Dagan, N. et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N. Engl. J. Med. 384, 1412–1423 (2021).
pubmed: 33626250
doi: 10.1056/NEJMoa2101765
Haas, E. J. et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 397, 1819–1829 (2021).
pubmed: 33964222
pmcid: 8099315
doi: 10.1016/S0140-6736(21)00947-8
Pilishvili, T. et al. Effectiveness of mRNA Covid-19 vaccine among U.S. health care personnel. N. Engl. J. Med. 385, e90 (2021).
pubmed: 34551224
doi: 10.1056/NEJMoa2106599
Tartof, S. Y. et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet 398, 1407–1416 (2021).
pubmed: 34619098
pmcid: 8489881
doi: 10.1016/S0140-6736(21)02183-8
Arbel, R. et al. BNT162b2 vaccine booster and mortality due to Covid-19. N. Engl. J. Med. 385, 2413–2420 (2021).
pubmed: 34879190
doi: 10.1056/NEJMoa2115624
Barda, N. et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet 398, 2093–2100 (2021).
pubmed: 34756184
pmcid: 8555967
doi: 10.1016/S0140-6736(21)02249-2
Phad, G. E. et al. Clonal structure, stability and dynamics of human memory B cells and circulating plasmablasts. Nat. Immunol. 23, 1076–1085 (2022).
pubmed: 35761085
pmcid: 9276532
doi: 10.1038/s41590-022-01230-1
Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186–193 (2022).
pubmed: 35105982
doi: 10.1038/s41590-021-01122-w
Oberhardt, V. et al. Rapid and stable mobilization of CD8(+) T cells by SARS-CoV-2 mRNA vaccine. Nature 597, 268–273 (2021).
pubmed: 34320609
pmcid: 8426185
doi: 10.1038/s41586-021-03841-4
Sahin, U. et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature 595, 572–577 (2021).
pubmed: 34044428
doi: 10.1038/s41586-021-03653-6
Sette, A. & Crotty, S. Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines. Immunol. Rev. 310, 27–46 (2022).
pubmed: 35733376
doi: 10.1111/imr.13089
Goel, R. R. et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science 374, abm0829 (2021).
pubmed: 34648302
pmcid: 9284784
doi: 10.1126/science.abm0829
Bange, E. M. et al. CD8(+) T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat. Med. 27, 1280–1289 (2021).
pubmed: 34017137
pmcid: 8291091
doi: 10.1038/s41591-021-01386-7
Gallais, F. et al. Intrafamilial exposure to SARS-CoV-2 associated with cellular immune response without seroconversion, France. Emerg. Infect. Dis. 27, 113–121 (2021).
pubmed: 33261718
pmcid: 7774579
doi: 10.3201/eid2701.203611
Cazzetta, V. et al. NKG2A expression identifies a subset of human Vdelta2 T cells exerting the highest antitumor effector functions. Cell Rep. 37, 109871 (2021).
pubmed: 34686325
doi: 10.1016/j.celrep.2021.109871
Mikulak, J. et al. NKp46-expressing human gut-resident intraepithelial Vdelta1 T cell subpopulation exhibits high antitumor activity against colorectal cancer. JCI Insight 4, e125884 (2019).
pubmed: 31689241
pmcid: 6975269
doi: 10.1172/jci.insight.125884
Bruni, E. et al. Intrahepatic CD69(+)Vdelta1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression. J. Immunother. Cancer 10, e004579 (2022).
pubmed: 35863820
pmcid: 9310256
doi: 10.1136/jitc-2022-004579
Hudspeth, K. et al. Engagement of NKp30 on Vdelta1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication. Blood 119, 4013–4016 (2012).
pubmed: 22403253
doi: 10.1182/blood-2011-11-390153
Sabbaghi, A. et al. Role of gammadelta T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches. Virol. J. 17, 174 (2020).
pubmed: 33183352
pmcid: 7659406
doi: 10.1186/s12985-020-01449-0
Poccia, F. et al. Antiviral reactivities of gammadelta T cells. Microbes Infect. 7, 518–528 (2005).
pubmed: 15777667
pmcid: 7110461
doi: 10.1016/j.micinf.2004.12.009
Garrido, C. et al. gammadelta T cells: an immunotherapeutic approach for HIV cure strategies. JCI Insight 3, e120121 (2018).
pubmed: 29925697
pmcid: 6124426
doi: 10.1172/jci.insight.120121
James, K. S. et al. Measuring the contribution of gammadelta T cells to the persistent HIV reservoir. AIDS 34, 363–371 (2020).
pubmed: 31764074
doi: 10.1097/QAD.0000000000002434
Bruni, E. et al. Chemotherapy accelerates immune-senescence and functional impairments of Vdelta2(pos) T cells in elderly patients affected by liver metastatic colorectal cancer. J. Immunother. Cancer 7, 347 (2019).
pubmed: 31829255
pmcid: 6907143
doi: 10.1186/s40425-019-0825-4
Caccamo, N., Dieli, F., Wesch, D., Jomaa, H. & Eberl, M. Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cells. J. Leukoc. Biol. 79, 663–666 (2006).
pubmed: 16461739
doi: 10.1189/jlb.1105640
Caccamo, N. et al. Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vgamma9Vdelta2 naive, memory and effector T cell subsets. Eur. J. Immunol. 35, 1764–1772 (2005).
pubmed: 15915537
doi: 10.1002/eji.200525983
von Massow, G., Oh, S., Lam, A., Gustafsson, K. & Gamma Delta, T. Cells and their involvement in COVID-19 virus infections. Front. Immunol. 12, 741218 (2021).
doi: 10.3389/fimmu.2021.741218
Sanz, M., Mann, B. T., Chitrakar, A. & Soriano-Sarabia, N. Defying convention in the time of COVID-19: Insights into the role of gammadelta T cells. Front. Immunol. 13, 819574 (2022).
pubmed: 36032159
pmcid: 9403327
doi: 10.3389/fimmu.2022.819574
Gay, L. et al. Vγ9Vδ2 T cells are potent inhibitors of SARS-CoV-2 replication and exert effector phenotypes in COVID-19 patients. Preprint at https://www.biorxiv.org/content/10.1101/2022.04.15.487518v1 (2022).
Wang, L. et al. COVID-19 vaccination influences subtypes of gammadelta-T cells during pregnancy. Front Immunol. 13, 900556 (2022).
pubmed: 36311780
pmcid: 9597631
doi: 10.3389/fimmu.2022.900556
Fichtner, A. S., Ravens, S. & Prinz, I. Human gammadelta TCR Repertoires in Health and Disease. Cells 9, 800 (2020).
pubmed: 32225004
pmcid: 7226320
doi: 10.3390/cells9040800
Davey, M. S. et al. The human Vdelta2(+) T-cell compartment comprises distinct innate-like Vgamma9(+) and adaptive Vgamma9(-) subsets. Nat. Commun. 9, 1760 (2018).
pubmed: 29720665
pmcid: 5932074
doi: 10.1038/s41467-018-04076-0
Muri, J. et al. The thioredoxin-1 system is essential for fueling DNA synthesis during T-cell metabolic reprogramming and proliferation. Nat. Commun. 9, 1851 (2018).
pubmed: 29749372
pmcid: 5945637
doi: 10.1038/s41467-018-04274-w
Wang, Y. et al. GATA-3 controls the maintenance and proliferation of T cells downstream of TCR and cytokine signaling. Nat. Immunol. 14, 714–722 (2013).
pubmed: 23708251
pmcid: 3688666
doi: 10.1038/ni.2623
Schluns, K. S., Kieper, W. C., Jameson, S. C. & Lefrancois, L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1, 426–432 (2000).
pubmed: 11062503
doi: 10.1038/80868
Gattinoni, L., Speiser, D. E., Lichterfeld, M. & Bonini, C. T memory stem cells in health and disease. Nat. Med 23, 18–27 (2017).
pubmed: 28060797
pmcid: 6354775
doi: 10.1038/nm.4241
Tan, L. et al. A fetal wave of human type 3 effector gammadelta cells with restricted TCR diversity persists into adulthood. Sci. Immunol. 6, eabf0125 (2021).
pubmed: 33893173
doi: 10.1126/sciimmunol.abf0125
Cerapio, J. P. et al. Phased differentiation of gammadelta T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers. Oncoimmunology 10, 1939518 (2021).
pubmed: 34721945
pmcid: 8555559
doi: 10.1080/2162402X.2021.1939518
Cano-Gamez, E. et al. Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4(+) T cells to cytokines. Nat. Commun. 11, 1801 (2020).
pubmed: 32286271
pmcid: 7156481
doi: 10.1038/s41467-020-15543-y
Kavazovic, I. et al. Eomes broadens the scope of CD8 T-cell memory by inhibiting apoptosis in cells of low affinity. PLoS Biol. 18, e3000648 (2020).
pubmed: 32182234
pmcid: 7077837
doi: 10.1371/journal.pbio.3000648
Pais Ferreira, D. et al. Central memory CD8(+) T cells derive from stem-like Tcf7(hi) effector cells in the absence of cytotoxic differentiation. Immunity 53, 985–1000.e11 (2020).
pubmed: 33128876
doi: 10.1016/j.immuni.2020.09.005
De Simone, G. et al. CXCR3 identifies human naive CD8(+) T cells with enhanced effector differentiation potential. J. Immunol. 203, 3179–3189 (2019).
pubmed: 31740485
pmcid: 6900484
doi: 10.4049/jimmunol.1901072
Sureshchandra, S. et al. Single-cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine. JCI Insight 6, e153201 (2021).
pubmed: 34935643
pmcid: 8783687
doi: 10.1172/jci.insight.153201
Caron, J., Ridgley, L. A. & Bodman-Smith, M. How to train your dragon: harnessing gamma delta T cells antiviral functions and trained immunity in a pandemic era. Front. Immunol. 12, 666983 (2021).
pubmed: 33854516
pmcid: 8039298
doi: 10.3389/fimmu.2021.666983
Jouan, Y. et al. Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients. J. Exp. Med 217, e20200872 (2020).
pubmed: 32886755
pmcid: 7472174
doi: 10.1084/jem.20200872
Lei, L. et al. The phenotypic changes of gammadelta T cells in COVID-19 patients. J. Cell Mol. Med. 24, 11603–11606 (2020).
pubmed: 32864865
pmcid: 7576249
doi: 10.1111/jcmm.15620
Zhang, J. Y. et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat. Immunol. 21, 1107–1118 (2020).
pubmed: 32788748
doi: 10.1038/s41590-020-0762-x
Carissimo, G. et al. Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19. Nat. Commun. 11, 5243 (2020).
pubmed: 33067472
pmcid: 7568554
doi: 10.1038/s41467-020-19080-6
Guo, C. et al. Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm. Nat. Commun. 11, 3924 (2020).
pubmed: 32764665
pmcid: 7413381
doi: 10.1038/s41467-020-17834-w
Odak, I. et al. Reappearance of effector T cells is associated with recovery from COVID-19. EBioMedicine 57, 102885 (2020).
pubmed: 32650275
pmcid: 7338277
doi: 10.1016/j.ebiom.2020.102885
Rijkers, G., Vervenne, T. & van der Pol, P. More bricks in the wall against SARS-CoV-2 infection: involvement of gamma9delta2 T cells. Cell Mol. Immunol. 17, 771–772 (2020).
pubmed: 32467616
pmcid: 7331628
doi: 10.1038/s41423-020-0473-0
Atmeh, P. A. et al. Macrophages and gammadelta T cells interplay during SARS-CoV-2 variants infection. Front. Immunol. 13, 1078741 (2022).
pubmed: 36601113
pmcid: 9806226
doi: 10.3389/fimmu.2022.1078741
Sanz, M. et al. Deep characterization of human gammadelta T cell subsets defines shared and lineage-specific traits. Front. Immunol. 14, 1148988 (2023).
pubmed: 37063856
pmcid: 10102470
doi: 10.3389/fimmu.2023.1148988
Lalor, S. J. & McLoughlin, R. M. Memory gammadelta T cells-newly appreciated protagonists in infection and immunity. Trends Immunol. 37, 690–702 (2016).
pubmed: 27567182
doi: 10.1016/j.it.2016.07.006
Hoft, D. F., Brown, R. M. & Roodman, S. T. Bacille Calmette-Guerin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J. Immunol. 161, 1045–1054 (1998).
pubmed: 9670986
doi: 10.4049/jimmunol.161.2.1045
Gela, A. et al. Effects of BCG vaccination on donor unrestricted T cells in two prospective cohort studies. EBioMedicine 76, 103839 (2022).
pubmed: 35149285
pmcid: 8842032
doi: 10.1016/j.ebiom.2022.103839
Shen, Y. et al. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 295, 2255–2258 (2002).
pubmed: 11910108
pmcid: 2872146
doi: 10.1126/science.1068819
Suliman, S. et al. Bacillus Calmette-Guerin (BCG) revaccination of adults with latent Mycobacterium tuberculosis infection induces long-lived BCG-reactive NK cell responses. J. Immunol. 197, 1100–1110 (2016).
pubmed: 27412415
doi: 10.4049/jimmunol.1501996
Sheridan, B. S. et al. gammadelta T cells exhibit multifunctional and protective memory in intestinal tissues. Immunity 39, 184–195 (2013).
pubmed: 23890071
pmcid: 3749916
doi: 10.1016/j.immuni.2013.06.015
Ravens, S. et al. Human gammadelta T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection. Nat. Immunol. 18, 393–401 (2017).
pubmed: 28218745
doi: 10.1038/ni.3686
Ruckert, T., Lareau, C. A., Mashreghi, M. F., Ludwig, L. S. & Romagnani, C. Clonal expansion and epigenetic inheritance of long-lasting NK cell memory. Nat. Immunol. 23, 1551–1563 (2022).
pubmed: 36289449
pmcid: 9663309
doi: 10.1038/s41590-022-01327-7
Larsen, S. B. et al. Establishment, maintenance, and recall of inflammatory memory. Cell Stem Cell 28, 1758–1774.e1758 (2021).
pubmed: 34320411
pmcid: 8500942
doi: 10.1016/j.stem.2021.07.001
Mascellino, M. T., Di Timoteo, F., De Angelis, M. & Oliva, A. Overview of the main anti-SARS-CoV-2 Vaccines: mechanism of action, efficacy and safety. Infect. Drug Resist. 14, 3459–3476 (2021).
pubmed: 34511939
pmcid: 8418359
doi: 10.2147/IDR.S315727
Teijaro, J. R. & Farber, D. L. COVID-19 vaccines: modes of immune activation and future challenges. Nat. Rev. Immunol. 21, 195–197 (2021).
pubmed: 33674759
pmcid: 7934118
doi: 10.1038/s41577-021-00526-x
Ferreira, L. M. Gammadelta T cells: innately adaptive immune cells? Int. Rev. Immunol. 32, 223–248 (2013).
pubmed: 23617235
doi: 10.3109/08830185.2013.783831
Xia, Y. et al. The mevalonate pathway is a druggable target for vaccine adjuvant discovery. Cell 175, 1059–1073.e21 (2018).
pubmed: 30270039
doi: 10.1016/j.cell.2018.08.070
Blazquez, J. L., Benyamine, A., Pasero, C. & Olive, D. New insights into the regulation of gammadelta T cells by BTN3A and other BTN/BTNL in tumor immunity. Front. Immunol. 9, 1601 (2018).
pubmed: 30050536
pmcid: 6050389
doi: 10.3389/fimmu.2018.01601
Marzano, P. et al. Transcriptomic profile of TNF(high) MAIT cells is linked to B cell response following SARS-CoV-2 vaccination. Front. Immunol. 14, 1208662 (2023).
pubmed: 37564651
pmcid: 10410451
doi: 10.3389/fimmu.2023.1208662
Cimini, E. et al. Interferon-alpha improves phosphoantigen-induced Vgamma9Vdelta2 T-cells interferon-gamma production during chronic HCV infection. PLoS One 7, e37014 (2012).
pubmed: 22629350
pmcid: 3358305
doi: 10.1371/journal.pone.0037014
Domae, E., Hirai, Y., Ikeo, T., Goda, S. & Shimizu, Y. Cytokine-mediated activation of human ex vivo-expanded Vgamma9Vdelta2 T cells. Oncotarget 8, 45928–45942 (2017).
pubmed: 28521284
pmcid: 5542238
doi: 10.18632/oncotarget.17498
Xi, X., Han, X., Li, L. & Zhao, Z. gammadelta T cells response to Mycobacterium tuberculosis in pulmonary tuberculosis patients using preponderant complementary determinant region 3 sequence. Indian J. Med. Res. 134, 356–361 (2011).
pubmed: 21985819
pmcid: 3193717
Xi, X. et al. A novel strategy to screen Bacillus Calmette-Guerin protein antigen recognized by gammadelta TCR. PLoS One 6, e18809 (2011).
pubmed: 21526117
pmcid: 3081299
doi: 10.1371/journal.pone.0018809
Xi, X., Han, X., Li, L. & Zhao, Z. Identification of a new tuberculosis antigen recognized by gammadelta T cell receptor. Clin. Vaccin. Immunol. 20, 530–539 (2013).
doi: 10.1128/CVI.00584-12
Cheng, C. et al. Next generation sequencing reveals changes of the gammadelta T cell receptor repertoires in patients with pulmonary tuberculosis. Sci. Rep. 8, 3956 (2018).
pubmed: 29500378
pmcid: 5834497
doi: 10.1038/s41598-018-22061-x
Li, H. et al. Structure of the Vdelta domain of a human gammadelta T-cell antigen receptor. Nature 391, 502–506 (1998).
pubmed: 9461220
doi: 10.1038/35172
Brummelman, J. et al. High-dimensional single cell analysis identifies stem-like cytotoxic CD8(+) T cells infiltrating human tumors. J. Exp. Med. 215, 2520–2535 (2018).
pubmed: 30154266
pmcid: 6170179
doi: 10.1084/jem.20180684
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
pubmed: 31740819
pmcid: 6884693
doi: 10.1038/s41592-019-0619-0
Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381–386 (2014).
pubmed: 24658644
pmcid: 4122333
doi: 10.1038/nbt.2859
Sturm, G. et al. Scirpy: a Scanpy extension for analyzing single-cell T-cell receptor-sequencing data. Bioinformatics 36, 4817–4818 (2020).
pubmed: 32614448
pmcid: 7751015
doi: 10.1093/bioinformatics/btaa611
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e29 (2021).
pubmed: 34062119
pmcid: 8238499
doi: 10.1016/j.cell.2021.04.048